|
HY-P74742-10ug
|
MedChemexpress LLC
|
MST1/STK4, Human (sf9, His)
|
|
|
|
|
HY-P74742-50ug
|
MedChemexpress LLC
|
MST1/STK4, Human (sf9, His)
|
|
|
|
|
HY-141510-10mg
|
MedChemexpress LLC
|
myo-Inositol trispyrophosphate (hexasodium) [CAS 23103-35-7]
|
|
Cancer-programmed cell death
|
|
|
HY-141510-100mg
|
MedChemexpress LLC
|
myo-Inositol trispyrophosphate (hexasodium) [CAS 23103-35-7]
|
|
Cancer-programmed cell death
|
|
|
HY-141510-25mg
|
MedChemexpress LLC
|
myo-Inositol trispyrophosphate (hexasodium) [CAS 23103-35-7]
|
|
Cancer-programmed cell death
|
|
|
HY-141510-5mg
|
MedChemexpress LLC
|
myo-Inositol trispyrophosphate (hexasodium) [CAS 23103-35-7]
|
|
Cancer-programmed cell death
|
|
|
HY-141510-50mg
|
MedChemexpress LLC
|
myo-Inositol trispyrophosphate (hexasodium) [CAS 23103-35-7]
|
|
Cancer-programmed cell death
|
|
|
HY-P77106-10ug
|
MedChemexpress LLC
|
NKp30/NCR3, Rat (HEK293, His)
|
|
|
|
|
HY-P77106-100ug
|
MedChemexpress LLC
|
NKp30/NCR3, Rat (HEK293, His)
|
|
|
|
|
HY-P77106-5ug
|
MedChemexpress LLC
|
NKp30/NCR3, Rat (HEK293, His)
|
|
|
|
|
HY-P77106-50ug
|
MedChemexpress LLC
|
NKp30/NCR3, Rat (HEK293, His)
|
|
|
|
|
HY-P77106-500ug
|
MedChemexpress LLC
|
NKp30/NCR3, Rat (HEK293, His)
|
|
|
|
|
HY-W127393-5mg
|
MedChemexpress LLC
|
N-Nonanoyl-L-homoserine lactone [CAS 177158-21-3]
|
|
|
|
|
HY-W127487-10mg
|
MedChemexpress LLC
|
N-Octadecanoyl-L-homoserine lactone [CAS 479050-96-9]
|
|
|
|
|
HY-114773-5mg
|
MedChemexpress LLC
|
N-Undecanoyl-L-homoserine lactone [CAS 216596-71-3]
|
|
|
|
|
HY-153890-1mg
|
MedChemexpress LLC
|
NVOC cage-TMP-Halo [CAS 2137894-98-3]
|
|
|
|
|
HY-153890-10mg
|
MedChemexpress LLC
|
NVOC cage-TMP-Halo [CAS 2137894-98-3]
|
|
|
|
|
HY-153890-5mg
|
MedChemexpress LLC
|
NVOC cage-TMP-Halo [CAS 2137894-98-3]
|
|
|
|
|
HY-16994-10mg
|
MedChemexpress LLC
|
OICR-0547 [CAS 1801873-49-3]
|
|
Cancer-programmed cell death
|
|
|
HY-16994-100mg
|
MedChemexpress LLC
|
OICR-0547 [CAS 1801873-49-3]
|
|
Cancer-programmed cell death
|
|
|
HY-16994-25mg
|
MedChemexpress LLC
|
OICR-0547 [CAS 1801873-49-3]
|
|
Cancer-programmed cell death
|
|
|
HY-16994-5mg
|
MedChemexpress LLC
|
OICR-0547 [CAS 1801873-49-3]
|
|
Cancer-programmed cell death
|
|
|
HY-16994-50mg
|
MedChemexpress LLC
|
OICR-0547 [CAS 1801873-49-3]
|
|
Cancer-programmed cell death
|
|
|
HY-16994-1mL
|
MedChemexpress LLC
|
OICR-0547 [CAS 1801873-49-3] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-P72010-10ug
|
MedChemexpress LLC
|
OMA1, Human (Cell-Free, His-SUMO)
|
|
|
|
